This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
[Retracted] Effect of interventional embolotherapy on FHIT and p16 expression in hepatocellular carcinoma patients
Wei Xu, Xiaogai Qi, Xia Wang, Jize Sun
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsFerroptosis and cancer prognosis
Oncol Lett 17: 871–876, 2019; DOI: 10.3892/ol.2018.9648
Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the control western blot data shown in Fig. 3 on p. 874 were strikingly similar to data that were already under consideration for publication in another article written by different authors at different research institutes. Owing to the fact that the contentious data in the above article had already been submitted for publication prior to its submission to Oncology Letters, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused.